# Oral Versus Patch Hormonal Contraceptive Effects on Metabolism, Clotting, Inflammatory Factors and Vascular Reactivity

> **NCT00439972** · PHASE2 · UNKNOWN · sponsor: **University of Washington** · enrollment: 36 (estimated)

## Conditions studied

- Contraception

## Interventions

- **DRUG:** Ortho-Cyclen (R)
- **DRUG:** Ortho Evra (R)
- **DRUG:** extended use of Ortho Evra (R)

## Key facts

- **NCT ID:** NCT00439972
- **Lead sponsor:** University of Washington
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2007-02
- **Primary completion:** 2011-12
- **Final completion:** 2011-12
- **Target enrollment:** 36 (ESTIMATED)
- **Last updated:** 2011-02-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00439972

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00439972, "Oral Versus Patch Hormonal Contraceptive Effects on Metabolism, Clotting, Inflammatory Factors and Vascular Reactivity". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT00439972. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*